Search Results

There are 18679 results for: content related to: Anti–prostate-Specific membrane antigen-based radioimmunotherapy for prostate cancer

  1. Prospects of medium specific activity 177Lu in targeted therapy of prostate cancer using 177Lu-labeled PSMA inhibitor

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 59, Issue 9, July 2016, Pages: 364–371, Sudipta Chakraborty, Rubel Chakravarty, Priyalata Shetty, K. V. Vimalnath, Ishita B. Sen and Ashutosh Dash

    Version of Record online : 6 JUN 2016, DOI: 10.1002/jlcr.3414

  2. You have free access to this content
    Oral Abstracts

    Internal Medicine Journal

    Volume 46, Issue S1, April 2016, Pages: 5–25,

    Version of Record online : 20 APR 2016, DOI: 10.1111/imj.13064

  3. Targeted treatment of prostate cancer

    Journal of Cellular Biochemistry

    Volume 102, Issue 3, 15 October 2007, Pages: 571–579, Xinning Wang, Lihong Yin, Pravin Rao, Robert Stein, Kelley M. Harsch, Zhenghong Lee and Warren D.W. Heston

    Version of Record online : 8 AUG 2007, DOI: 10.1002/jcb.21491

  4. You have free access to this content
    Poster Abstracts

    Internal Medicine Journal

    Volume 46, Issue S1, April 2016, Pages: 26–44,

    Version of Record online : 20 APR 2016, DOI: 10.1111/imj.13065

  5. An Anti-PSMA Bivalent Immunotoxin Exhibits Specificity and Efficacy for Prostate Cancer Imaging and Therapy

    Advanced Healthcare Materials

    Volume 2, Issue 5, May, 2013, Pages: 736–744, Fayun Zhang, Liang Shan, Yuanyi Liu, David Neville, Jung-Hee Woo, Yue Chen, Alexandru Korotcov, Stephen Lin, Sophia Huang, Rajagopalan Sridhar, Wei Liang and Paul C. Wang

    Version of Record online : 22 NOV 2012, DOI: 10.1002/adhm.201200254

  6. Saporin toxin-conjugated monoclonal antibody targeting prostate-specific membrane antigen has potent anticancer activity

    The Prostate

    Volume 70, Issue 12, 1 September 2010, Pages: 1286–1294, Kenji Kuroda, He Liu, Sae Kim, Ming Guo, Vincent Navarro and Neil H. Bander

    Version of Record online : 5 APR 2010, DOI: 10.1002/pros.21164

  7. You have free access to this content
    Oral Presentations

    Internal Medicine Journal

    Volume 45, Issue S1, April 2015, Pages: 1–20,

    Version of Record online : 13 APR 2015, DOI: 10.1111/imj.12728

  8. Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene

    The Prostate

    Volume 58, Issue 2, 1 February 2004, Pages: 200–210, Denise S. O'Keefe, Dean J. Bacich and Warren D.W. Heston

    Version of Record online : 4 NOV 2003, DOI: 10.1002/pros.10319

  9. You have free access to this content
    Inhibition of prostate-specific membrane antigen (PSMA)-positive tumor growth by vaccination with either full-length or the C-terminal end of PSMA

    International Journal of Cancer

    Volume 102, Issue 3, 20 November 2002, Pages: 244–249, Katsuyuki Kuratsukuri, Tomomichi Sone, Ching Y. Wang, Nobuyasu Nishisaka, Richard F. Jones and Gabriel P. Haas

    Version of Record online : 19 SEP 2002, DOI: 10.1002/ijc.10700

  10. A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer

    The Prostate

    Volume 66, Issue 13, 15 September 2006, Pages: 1359–1370, Ursula Elsässer-Beile, Philipp Wolf, Dorothee Gierschner, Patrick Bühler, Wolfgang Schultze-Seemann and Ulrich Wetterauer

    Version of Record online : 7 AUG 2006, DOI: 10.1002/pros.20367

  11. Prostate-Cancer-Targeted N-(2-Hydroxypropyl)methacrylamide Copolymer/Docetaxel Conjugates

    Macromolecular Bioscience

    Volume 12, Issue 3, March 2012, Pages: 412–422, Jihua Liu, Pavla Kopečková, Huaizhong Pan, Monika Sima, Patrick Bühler, Philipp Wolf, Ursula Elsässer-Beile and Jindřich Kopeček

    Version of Record online : 16 JAN 2012, DOI: 10.1002/mabi.201100340

  12. High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer

    The Prostate

    Volume 71, Issue 3, 15 February 2011, Pages: 281–288, Sarah Minner, Corinna Wittmer, Markus Graefen, Georg Salomon, Thomas Steuber, Alexander Haese, Hartwig Huland, Carsten Bokemeyer, Emre Yekebas, Judith Dierlamm, Stefan Balabanov, Ergin Kilic, Waldemar Wilczak, Ronald Simon, Guido Sauter and Thorsten Schlomm

    Version of Record online : 31 AUG 2010, DOI: 10.1002/pros.21241

  13. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers


    Volume 122, Issue 6, June 2014, Pages: 482–489, Alla Gabriella Wernicke, Sonal Varma, Eleni A. Greenwood, Paul J. Christos, K. S. Clifford Chao, He Liu, Neil H. Bander and Sandra J. Shin

    Version of Record online : 5 DEC 2013, DOI: 10.1111/apm.12195

  14. Immunoconjugates Against Solid Tumors: Mind the Gap

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue 4, April 2011, Pages: 513–523, AD Ricart

    Version of Record online : 2 MAR 2011, DOI: 10.1038/clpt.2011.8

  15. Anti-prostate specific membrane antigen designer T cells for prostate cancer therapy

    The Prostate

    Volume 61, Issue 1, 15 September 2004, Pages: 12–25, Qiangzhong Ma, Mazin Safar, Eric Holmes, Yawen Wang, Alton L. Boynton and Richard P. Junghans

    Version of Record online : 5 MAR 2004, DOI: 10.1002/pros.20073

  16. Synthesis and in vitro evaluation of MR molecular imaging probes using J591 mAb-conjugated SPIONs for specific detection of prostate cancer

    Contrast Media & Molecular Imaging

    Volume 8, Issue 2, March/April 2013, Pages: 175–184, Mohammad Abdolahi, Daryoush Shahbazi-Gahrouei, Sophie Laurent, Corine Sermeus, Farzin Firozian, Barry J. Allen, Sebastien Boutry and Robert N. Muller

    Version of Record online : 20 DEC 2012, DOI: 10.1002/cmmi.1514

  17. Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer

    Contrast Media & Molecular Imaging

    Volume 9, Issue 3, May/June 2014, Pages: 211–220, Mehdi Evazalipour, Matthias D'Huyvetter, Bahram Soltani Tehrani, Mohsen Abolhassani, Kobra Omidfar, Shahriyar Abdoli, Roghaye Arezumand, Hamid Morovvati, Tony Lahoutte, Serge Muyldermans and Nick Devoogdt

    Version of Record online : 6 MAR 2014, DOI: 10.1002/cmmi.1558

  18. A phosphoramidate-based prostate-specific membrane antigen-targeted SPECT agent

    The Prostate

    Volume 72, Issue 8, 1 June 2012, Pages: 904–912, Jessie R. Nedrow-Byers, Mohamed Jabbes, Cayla Jewett, Tanushree Ganguly, Haiyang He, Tiancheng Liu, Paul Benny, Jeffrey N. Bryan and Clifford E. Berkman

    Version of Record online : 5 OCT 2011, DOI: 10.1002/pros.21493

  19. Synergistic co-targeting of prostate-specific membrane antigen and androgen receptor in prostate cancer

    The Prostate

    Volume 75, Issue 3, February 15, 2015, Pages: 242–254, Jose D. Murga, Sameer M. Moorji, Amy Q. Han, Wells W. Magargal, Vincent A. DiPippo and William C. Olson

    Version of Record online : 18 OCT 2014, DOI: 10.1002/pros.22910

  20. Development and Screening of a Series of Antibody-Conjugated and Silica-Coated Iron Oxide Nanoparticles for Targeting the Prostate-Specific Membrane Antigen


    Volume 9, Issue 7, July 2014, Pages: 1356–1360, Dr. Amarnath Mukherjee, Dr. Thomas Darlington, Dr. Richard Baldwin, Charles Holz, Sage Olson, Dr. Prakash Kulkarni, Dr. Theodore L. DeWeese, Dr. Robert H. Getzenberg, Dr. Robert Ivkov and Dr. Shawn E. Lupold

    Version of Record online : 3 MAR 2014, DOI: 10.1002/cmdc.201300549